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expressed gene was PLK1 by 12 times, and was also found to be
over-expressed in Huh-7 cells. SiRNA against PLK-1 validated by
real-time PCR (RTPCR) and Western Blotting showed a reduction
of PLKR1 expression up to 96% in huh-7 cells, and reduced cell
proliferation by 68% and 92% in MTS and BrdU cell proliferation as-
says respectively. There was 3-fold increase in apoptosis events,
and TUNEL staining and caspase-3 assays suggested that this may
be caspase-independent. The pan-caspase inhibitor Z-VAD-FMK
was unable to rescue apoptotic cells. Immnoﬂuorescence studies
co-localised endonuclease G to fragmented chromosomes, thus
was postulated to be the main apoptotic effector. Knockdown
of the FOXM1 transcription factor, thought to be a positive reg-
ulating factor did not affect PLK1 gene expression, suggesting
other transcription factors may be important. Finally, huh-7 cells
transplanted subcutaneously into nude mice using matrigel were
treated with si-PLK1 and control si-RNA. Tumour regression of
33% occurred in the mice treated with si-PLK1 but not in controls.
Conclusion: PLK1 overexpression in HCC was shown to be func-
tionally important by gene silencing experiments, and may be a
potential therapeutic target.
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MRSA is the leading cause of nosocomial infection in Latin Amer-
ica, and the number of reports of community-acquired (cMRSA)
infections continue to rise.
The full extent of the problem is unknown because surveillance
information is only available from large hospitals, while much
of the population is cared for in small centers that do not per-
form microbiological testing or use different methodology and
deﬁnitions. Under these conditions, monitoring the epidemiology
of MRSA remains a challenge and there is a need to improve
detection and management.
Nosocomial, multidrug-resistant MRSA is a growing problem in
Latin America with estimated prevalence for the region currently
near or above 50% for non blood stream infections and over 40%
for bacteremia.
Reports of CA-MRSA infections initially came from Brazil in 2003.
Soon, a large outbreak of CA-MRSA infection that affected in-
mates in jails and people from the community in Uruguay was
described; more than 1000 patients were affected and 12 died.
In the region SSTIs account for the majority of cases, but severe
forms of pneumonia were reported, including 4 deaths. In this
outbreak, TMP-SMX remains active in vitro and is used for the
treatment of skin infections.
Interestingly, an apparent decrease in MRSA strains with van-
comycin MIC greater or equal to 1 μg/ml suggests a shift in clonal
dissemination, and further data are required to follow this trend,
which may have important implications for treatment.
Although surveillance systems in Latin America are improving,
many limitations remain.
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Methicillin-resistant Staphylococcus aureus (MRSA) is a leading
cause of hospital-acquired infections and an increasingly recog-
nized pathogen from the community worldwide. MRSA infections
are associated with high morbidity and mortality, and are a major
ﬁnancial burden to healthcare globally.
A number of typing methods, including pulsed-ﬁeld gel elec-
trophoresis (PFGE), has been used by international surveillance
networks to study the relationships and spread of MRSA iso-
lates geographically. It was established that the large majority
of MRSA isolates belong to a limited set of epidemic clones
worldwide, namely the Brazilian, Iberian, New York/Japan, Pae-
diatric clones. Methicillin resistance is conferred by the penicillin
binding protein PBP2’, encoded by the mecA gene, present in
a large fragment of mobile DNA designated “staphylococcal
cassette chromosome”, SCCmec. More recently, sequence-based
methods have been employed in the analyses of these isolates.
Multilocus sequence typing (MLST) requires the sequence de-
termination of internal fragments of 7 housekeeping genes for
each strain. Each identical sequence is assigned an allele num-
ber, and the combination of alleles at each locus deﬁnes its
sequence type (ST). The combination of MLST and SCCmec typing
applied on international collections of MRSA revealed that these
epidemic MRSA clones emerged on repeated acquisition (over
20 times) of SCCmec by successful methicillin-susceptible S.
aureus (MSSA) clones belonging to ﬁve phylogenetically distinct
lineages or clonal complexes (CCs): CC8, CC5, CC45, CC22 and
CC30.
MRSA is endemic in Hong Kong hospitals. Our previous study
on MRSA causing bacteremia in Hong Kong hospitals belonged
to four clonal complexes CC5, CC45, CC49 and CC239. The
most prevalent MRSA clone in Hong Kong belonged to CC239,
with PFGE types A-E, and H, SCCmec type III, and belonged to
sequence type, ST239, with a multidrug resistance proﬁle to
tetracycline (T), erythromycin (E), clindamycin (D), gentamicin
(G), tobramycin (To) and ciproﬂoxacin (Ci). Evidence also sup-
ports the prevalence of CC239 in Asian countries including China,
Singapore, Taiwan, and Indonesia, whereas MRSA strains from
Korea and Japan belonged to CC5 that had SCCmec type II.
With advances in sequencing technology, the evolutionary history
of the MRSA clone ST5 was further studied by mutation discovery
at 108 loci (46kb) within a global collection. Sequence polymor-
phisms in 1.6% (46,483 bp) of the genome from each MRSA strain
was screened. The SNPS deﬁned a radial phylogenetic structure
within ST5 consisting of at least 5 chains of mutational steps that
deﬁne geographically associated clades. Mapping of the indepen-
dent imports of the SCCmec demonstrated import occurred at
least 23 occasions, and that the progeny of such recombinant
strains are locally rather than globally. This further exempliﬁes
that geographical spread of MRSA over long distances and across
cultural borders is a rare event compared with the frequency
with which SCCmec has been imported.
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MRSA became the most common nosocomial pathogen in many
hospitals since the 1980s, especially in many Asian countries. Epi-
demiologic reports showed that >50% of S. aureus isolates from
the hospitals in Korea, Japan, Taiwan, Hong Kong, Singapore,
and Sri Lanka were MRSA. MRSA infection is now increasingly
reported in the community. According to the ANSORP study from
2004 to 2006 in 9 Asian countries, the prevalence of MRSA among
community-associated S. aureus isolates was 20.8% in Asian re-
gion and it was the highest in Taiwan (40.5%), followed by Sri
Lanka (38.8%), the Philippines (30.1%), and Vietnam (28.2%).
Skin and soft tissue infection was the most common infection by
community-associated MRSA (CA-MRSA) followed by respiratory
tract infection and primary bacteremia. CA-MRSA isolates from
Asian region showed diverse microbiologic and genetic features
